Immunological responses in mice to full-thickness corneal grafts engineered from porcine collagen

Biomaterials

Volumn 28, Issue 26, 2007, Pages 3807-3814

  Liu, Lei ^a   Kuffová, Lucia ^a   Griffith, May ^b,c   Dang, Zexu ^a   Muckersie, Elizabeth ^a   Liu, Yuwen ^d   McLaughlin, Christopher R ^b,c   Forrester, John V ^a  

^a Institute of Medical Science   (United Kingdom)

^b UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Immunology; Keratoplasty; Porcine collagen; Tissue engineered cornea

Indexed keywords

KERATOPLASTY; PORCINE COLLAGEN; SODIUM CITRATE; TISSUE ENGINEERED CORNEA;

BIOCOMPATIBILITY; CROSSLINKING; FLOW CYTOMETRY; IMMUNOLOGY; OPHTHALMOLOGY; RATS; TISSUE ENGINEERING;

COLLAGEN;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; CITRATE SODIUM; COLLAGEN; COLLAGEN TYPE 1; FIBRIN; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; BIOCOMPATIBILITY; BONE MARROW CELL; CELL INFILTRATION; CONTROLLED STUDY; CORNEA TRANSPLANTATION; FLOW CYTOMETRY; GRANULOCYTE; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPH NODE; MACROPHAGE; MEMBRANE FORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TISSUE ENGINEERING;

ANIMALS; COLLAGEN TYPE I; CORNEAL TRANSPLANTATION; EQUIPMENT FAILURE ANALYSIS; GRAFT SURVIVAL; MICE; MICE, INBRED BALB C; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN; SWINE; TISSUE ENGINEERING; TREATMENT OUTCOME;

MURINAE; MUS; SUS;

EID: 34447275744     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.04.025     Document Type: Article

References (30)

1. United Kingdom Transplant Support Service Authority Transplant Update 1999. Bristol. 1999.
2. Williams K.A., Muehlberg S.M., and Lewis R.F. The Australian corneal graft registry 1996 report (1997), Mercury Press, Adelaide p. 11
3. Williams K.A., Roder D., Esterman A., Muehlberg S.M., and Coster D.J. Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. Ophthalmology 99 3 (1992) 403-414
4. Hicks C.R., Fitton J.H., Chirila T.V., Crawford G.J., and Constable I.J. Keratoprostheses: advancing toward a true artificial cornea. Surv Ophthalmol 42 2 (1997) 175-189
5. Khan B., Dudenhoefer E.J., and Dohlman C.H. Keratoprosthesis: an update. Curr Opin Ophthalmol 12 4 (2001) 282-287
6. Barber J.C. Keratoprosthesis: past and present. Int Ophthalmol Clin 28 2 (1988) 103-109
7. Gomes M.E., and Reis R.L. Tissue engineering: key elements and some trends. Macromol Biosci 4 8 (2004) 737-742
8. Carlsson D.J., Li F., Shimmura S., and Griffith M. Bioengineered corneas: how close are we?. Curr Opin Ophthalmol 14 4 (2003) 192-197
9. Griffith M., Hakim M., Shimmura S., Watsky M.A., Li F., Carlsson D., et al. Artificial human corneas: scaffolds for transplantation and host regeneration. Cornea 21 7 Suppl (2002) S54-S61
10. Minami Y., Sugihara H., and Oono S. Reconstruction of cornea in three-dimensional collagen gel matrix culture. Invest Ophthalmol Vis Sci 34 7 (1993) 2316-2324
11. Zieske J.D., Mason V.S., Wasson M.E., Meunier S.F., Nolte C.J., Fukai N., et al. Basement membrane assembly and differentiation of cultured corneal cells: importance of culture environment and endothelial cell interaction. Exp Cell Res 214 2 (1994) 621-633
12. Schneider A.I., Maier-Reif K., and Graeve T. Constructing an in vitro cornea from cultures of the three specific corneal cell types. In Vitro Cell Dev Biol Anim 35 9 (1999) 515-526
13. Tegtmeyer S., Reichl S., and Muller-Goymann C.C. Cultivation and characterization of a bovine in vitro model of the cornea. Pharmazie 59 6 (2004) 464-471
14. Tegtmeyer S., Papantoniou I., and Muller-Goymann C.C. Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride. Eur J Pharm Biopharm 51 2 (2001) 119-125
15. Griffith M., Osborne R., Munger R., Xiong X., Doillon C.J., Laycock N.L., et al. Functional human corneal equivalents constructed from cell lines. Science 286 5447 (1999) 2169-2172
16. Germain L., Auger F.A., Grandbois E., Guignard R., Giasson M., Boisjoly H., et al. Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology 67 3 (1999) 140-147
17. Li F., Carlsson D., Lohmann C., Suuronen E., Vascotto S., Kobuch K., et al. Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc Natl Acad Sci USA 100 26 (2003) 15346-15351
18. Liu Y., Gan L., Carlsson D.J., Fagerholm P., Lagali N., Watsky M.A., et al. A simple, cross-linked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci 47 5 (2006) 1869-1875
19. Cahane M. Artificial cornea and the future of eye banking. Cell Tissue Bank 1 4 (2000) 319-320
20. Lee C.H., Singla A., and Lee Y. Biomedical applications of collagen. Int J Pharm 221 1-2 (2001) 1-22
21. Wallace D.G., and Rosenblatt J. Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev 55 12 (2003) 1631-1649
22. Kuffova L., Lumsden L., Vesela V., Taylor J.A., Filipec M., Holan V., et al. Kinetics of leukocyte and myeloid cell traffic in the murine corneal allograft response. Transplantation 72 7 (2001) 1292-1298
23. Plskova J., Kuffova L., Holan V., Filipec M., and Forrester J.V. Evaluation of corneal graft rejection in a mouse model. Br J Ophthalmol 86 1 (2002) 108-113
24. Plskova J., Holan V., Filipec M., and Forrester J.V. Lymph node removal enhances corneal graft survival in mice at high risk of rejection. BMC Ophthalmol 4 1 (2004) 3
25. Kuffova L., Holan V., Lumsden L., Forrester J.V., and Filipec M. Cell subpopulations in failed human corneal grafts. Br J Ophthalmol 83 12 (1999) 1364-1369
26. Khor E. Methods for the treatment of collagenous tissues for bioprostheses. Biomaterials 18 2 (1997) 95-105
27. Weadock K., Olson R.M., and Silver F.H. Evaluation of collagen crosslinking techniques. Biomater Med Devices Artif Organs 11 4 (1983) 293-318
28. Pieper J.S., Oosterhof A., Dijkstra P.J., Veerkamp J.H., and van Kuppevelt T.H. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 20 9 (1999) 847-858
29. Girard M.T., Matsubara M., Kublin C., Tessier M.J., Cintron C., and Fini M.E. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J Cell Sci 104 Pt 4 (1993) 1001-1011
30. Ross R., Everett N.B., and Tyler R. Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J Cell Biol 44 3 (1970) 645-654